학술논문

Metabolic and bariatric surgery in patients with class I obesity; a two-year follow-up
Document Type
Academic Journal
Source
BMC Surgery. January 3, 2024, Vol. 24 Issue 1
Subject
Care and treatment
Complications and side effects
Mortality
Mortgage backed securities
Surgery
Obesity -- Care and treatment -- Complications and side effects
Hernia -- Care and treatment -- Complications and side effects
Hypertension -- Care and treatment -- Complications and side effects
Bariatric surgery
Type 2 diabetes -- Complications and side effects -- Care and treatment
Body mass index
Sleep apnea -- Complications and side effects -- Care and treatment
Gastroesophageal reflux -- Care and treatment -- Complications and side effects
Obesity -- Care and treatment -- Complications and side effects -- Surgery
Mortgage-backed securities
Sleep apnea syndromes -- Complications and side effects -- Care and treatment
Language
English
ISSN
1471-2482
Abstract
Author(s): Mohammad Kermansaravi[sup.1,2], Rohollah Valizadeh[sup.3], Masoumeh Shahsavan[sup.4], Seyyed Adel Maleknia[sup.4], Foolad Eghbali[sup.1,2], Abdolreza Pazouki[sup.1,2] and Shahab Shahabi Shahmiri[sup.1,2] Introduction It is estimated that more than 650 million people are obese [...]
Background Patients with class I obesity may need metabolic and bariatric surgery (MBS) in the presence of obesity-associated medical problems, but MBS in this class of obesity is under debate. This study aimed to investigate the efficacy and safety of MBS in patients with class I obesity. Methods and materials This study was a historical cohort carried out on 112 patients with class I obesity with body mass index (BMI) of 30-35 kg/m.sup.2 with a 24-month follow-up underwent MBS at Rasoul-e-Akram Hospital. The required data were extracted through the Iran National Obesity Surgery Database. The data required for the study consisted of demographic information such as age, gender, and obesity-associated medical problems like type-2 diabetes mellitus (T2DM), hypertension, obstructive sleep apnea, and dyslipidemia before surgery, 6, 12, and 24 months after surgery. Results Mean age of the patients was 38.10 [+ or -] 10.04 years; mean BMI was 32.96 [+ or -] 1.35 kg/m.sup.2 and 83.9% (n = 94) of patients were female. Out of 18 patients with T2DM, 11 patients (61.11%) had complete remission and seven patients (38.88%) had partial remission. Obstructive sleep apnea, hypertension, dyslipidemia, and gastroesophageal reflux disease were observed in 18 (16.07%), 23 (20.53%), 43 (38.39%), and 13 patients (11.60%) before surgery and resolved at 24-month follow-up. Post-operative complications during the 24-month follow-up were checked to assess safety and there were no De novo gastroesophageal reflux disease, intolerance, leakage, pulmonary thromboembolism, deep vein thrombosis, incisional hernia, hypoalbuminemia (Albumin < 3.5 g/dl), excessive weight loss (BMI < 18.5 kg/m.sup.2) at any time during 24-months follow-ups and mortality. Early complications occurred as splenic injury in one case (0.89%), wound infection in one patient (0.89%), and extra-luminal bleeding in 10 (8.92%) after surgery, without any mortality. Conclusion MBS is safe and effective in class I obesity and can be considered in selected patients with obesity-associated medical problems. Keywords: Bariatric Surgery, Metabolic Surgery, Obesity, Low BMI